Isoquercitrin Attenuates Steatohepatitis by Inhibition of the Activated NLRP3 Inflammasome through HSP90

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease with a global prevalence of 25%. However, the medicines approved by the FDA or EMA are still not commercially available for the treatment of NAFLD. The NOD-like receptor thermal protein domain-associated protein 3 (NLRP3) inflammas...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ji, Li, Maoru, Yang, Tingting, Deng, Yang, Ding, Yadong, Guo, Tiantian, Shang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218527/
https://www.ncbi.nlm.nih.gov/pubmed/37240141
http://dx.doi.org/10.3390/ijms24108795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218527/
https://www.ncbi.nlm.nih.gov/pubmed/37240141
http://dx.doi.org/10.3390/ijms24108795

Ejemplares similares